PHILADELPHIA – Vincent Lo Re III, MD, MSCE, FIDSA, an assistant professor of Infectious Disease in the Perelman School of Medicine at the University of Pennsylvania was honored with the 2016 HIV Medicine Association (HIVMA) Research Award for his significant contributions to the field of HIV medicine. The award was presented on Thursday, Oct. 27 as part of IDWeek 2016 in New Orleans.

“It is an honor to be recognized with the HIVMA Research Award,” Lo Re said. “This week is about advancing science and research in order to better understand and treat infectious diseases and I am humbled that my work can contribute to this larger effort in some way.”

The HIVMA Research Award, given out annually during IDWeek, recognizes researchers who have made outstanding contributions to HIV medicine in clinical or basic research early in their careers. Through research, Lo Re has advanced the understanding of hepatitis infection in HIV-infected patients. He developed new methods to identify liver-related outcomes – particularly decompensated cirrhosis, acute hepatic failure and hepatocellular carcinoma – which are used by researchers throughout North America. Clinicians and policymakers cite his findings to justify initiating HCV treatment in chronic HIV-infected patients even in the absence of advanced hepatic fibrosis or cirrhosis.

Dr. Lo Re has authored more than 50 articles published in peer-reviewed publications and has been a member of the Food and Drug Administration’s Antiviral Drugs Advisory Committee (now the Antimicrobial Drugs Advisory Committee) since 2014. He received numerous young investigator awards and other honors, including recognition as one of the Best Doctors in America several times.

For full awards descriptions, recipient biographies and past award winners please visit HIVMA’s annual meeting, IDWeek 2016, takes place Oct. 26-30 at the Ernest N. Morial Convention Center in New Orleans. To learn more, visit

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.9 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $496 million awarded in the 2020 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 44,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2020, Penn Medicine provided more than $563 million to benefit our community.

Share This Page: